WeArable Neuromodulation DeVice for the TrEatment of Alzheimer's Disease

NAWithdrawnINTERVENTIONAL
0
Timeline

Start Date

December 31, 2023

Primary Completion Date

March 31, 2024

Study Completion Date

March 31, 2024

Conditions
Mild Alzheimer's Disease
Interventions
DEVICE

Non-invasive brainstem stimulation

Study participants will self-administer \~19-minute treatments twice daily in the home setting over 24 weeks using a non-invasive brainstem modulation device. All participants will use the same treatment mode during the open label extension.

Trial Locations (5)

23666

Riverside Neurology Specialists, Hampton

27157

Wake Forest University Health Sciences, Winston-Salem

27599

University of North Carolina at Chapel Hill, Chapel Hill

33486

Parkinson's Disease and Movement Disorders Center of Boca Raton, Boca Raton

33613

USF Health Byrd Alzheimer's Institute, Tampa

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Scion NeuroStim

INDUSTRY